Form 4: Zoetis Director Michael McCallister Reports Stock Transactions

Director Michael McCallister reports acquisition and disposition of Zoetis Inc. stock, including vesting of restricted stock units and shares sold for cash.

Summary

• On February 6, 2025, Michael McCallister, a director of Zoetis Inc., reported transactions involving the company's common stock.
• These transactions included the acquisition of 1,236 shares upon the vesting and settlement of restricted stock units (RSUs).
• McCallister also disposed of 316 shares for cash at a price of $174.12 per share.
• Following these transactions, McCallister directly owns 921 shares and indirectly owns 16,854 shares through a family trust, 6,160 shares through the Charlene McCallister Revocable Trust, and 2,840 shares through The Charlene G. McCallister 2022 Grantor Retained Annuity Trust.
• He also holds 1,225.4023 restricted stock units that will vest on February 8, 2022.

Sentiment

Score: 5

Explanation: The document is a neutral report of stock transactions, with no inherent positive or negative sentiment.

Industry Context

This Form 4 filing is a routine disclosure of stock transactions by a company insider, which is common practice among publicly traded companies. It provides transparency to investors regarding the trading activities of company directors.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies and their insiders, ensuring transparency in stock transactions.
• The reported transactions are typical for directors receiving and vesting stock-based compensation.
• Comparable companies like Elanco Animal Health also have similar insider transaction reporting requirements.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the director's stock activity, but the overall effect is likely minimal.

Key Dates

Keywords

Zoetis, Director, Stock Transactions, Form 4, Restricted Stock Units, Beneficial Ownership